 |
| Global Blood Plasma Derivatives Market Size |
Blood plasma derivatives are life-saving therapeutics that are extracted from
human blood plasma and are used to treat several critical conditions including
hemophilia, primary immunodeficiency disease, and other bleeding disorders.
Therapeutics extracted from blood plasma such as immunoglobulin, albumin,
Factor VIII, and Factor IX play a vital role in disease management and
treatment. The increasing prevalence of chronic diseases and growing demand for
effective biologics and therapeutics for disease management is fueling the
growth of the blood plasma derivatives market.
The global
Blood Plasma Derivatives Market is estimated to be valued at US$ 51.07 Bn in 2023 and is expected to exhibit a CAGR of 12. % over the forecast period
2024 to 2031, as highlighted in a new report published by Coherent Market
Insights.
Market key trends:
The increasing demand for blood plasma derivatives from emerging economies is
one of the key trends bolstering market growth. Factors such as the rising
geriatric population, growing incidence of chronic diseases, increasing
healthcare expenditure, and improving access to healthcare are fueling the
demand for plasma derivatives in emerging Asian and Latin American countries.
Moreover, growing awareness about the benefits of plasma-derived therapies
among patients and physicians in developing nations is further propelling the
market growth. Manufacturers are focusing on capacity expansion and new product
launches to cater to the surging demand from emerging economies, which will
continue to present remunerative opportunities for market players over the
forecast period.
Segment Analysis
The global blood plasma derivatives market can be segmented into albumin,
factor VIII, factor IX, immunoglobulins, hyperimmune globulins, and other
plasma derivatives. Albumin dominates the market currently due to its wide
applications in cancer, burns, shock, cirrhosis of liver and other disorders.
It helps maintain colloidal osmotic pressure in the blood vessels and
transports molecules like hormones, fatty acids and pharmaceuticals through the
body.
Key Takeaways
Global
Blood Plasma Derivatives Market Size
is expected to witness high growth over the forecast period of 2024 to
2031.
Regional analysis: North America currently dominates the global blood plasma
derivatives market. This is attributed to the presence of leading market
players, growing research & development activities, rising demand for
plasma products and increasing applications of immunoglobulins in the region.
Asia Pacific is anticipated to register the highest CAGR during the forecast
period owing to growing prevalence of bleeding and immune disorders, rising
healthcare spending, favourable reimbursement scenario and increasing patient
awareness in the region.
Key players operating in the blood plasma derivatives market are Iron Mountain,
ARC, Access, Shred-it, Restore plc, Cintas, Proshred, National Document
Shredding Service, Shred Station, Red Dog Shred, Shred-X, Secured Document
Shredding, Shred Works, Guardian Data Destruction, EndoShred, Mobile Shred,
ShredQuick, ProShred Chicago, Shreds Unlimited. These players are focusing on
new product launches, partnership agreements, and expansion of manufacturing
facilities to gain market share.
Get More Insights On This Topic: https://www.trendingwebwire.com/blood-plasma-derivatives-market-are-driven-by-growing-demand/